Prasugrel
- OralPrasugrelEffientA prodrug that requires enzymatic activation
- Mechanism of Action
- Irreversibly inhibits the binding of adenosine diphosphate (ADP) to platelet P2Y₁₂ receptors, resulting in reduced platelet activation and aggregation.
- Pharmacology
- A pro-drug that requires enzymatic activation.
Clinical Use
- Indications
- Contraindications
- Adverse Effects
- Haemorrhage.